D.A. Shaw

1.6k total citations
29 papers, 1.1k citations indexed

About

D.A. Shaw is a scholar working on Neurology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, D.A. Shaw has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 8 papers in Epidemiology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in D.A. Shaw's work include Acute Ischemic Stroke Management (7 papers), Cerebrovascular and Carotid Artery Diseases (4 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). D.A. Shaw is often cited by papers focused on Acute Ischemic Stroke Management (7 papers), Cerebrovascular and Carotid Artery Diseases (4 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). D.A. Shaw collaborates with scholars based in United Kingdom, United States and South Sudan. D.A. Shaw's co-authors include David O. Bates, N.E.F. Cartlidge, John Marshall, G.S. Venables, Andrew Weightman, P. Fawcett, A. Bradford Hill, J. W. D. Bull, Simon Nightingale and L. J. P. Duncan and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Journal of Hepatology.

In The Last Decade

D.A. Shaw

27 papers receiving 948 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.A. Shaw United Kingdom 17 269 231 197 196 173 29 1.1k
Doraid Jarrar United States 22 492 1.8× 286 1.2× 153 0.8× 83 0.4× 71 0.4× 43 1.7k
P. L. Wahi India 16 155 0.6× 258 1.1× 184 0.9× 34 0.2× 93 0.5× 68 1.2k
Erkan Cüre Türkiye 22 175 0.7× 99 0.4× 109 0.6× 176 0.9× 176 1.0× 102 1.4k
Ursula Steckholzer Switzerland 15 782 2.9× 227 1.0× 146 0.7× 79 0.4× 37 0.2× 21 1.8k
Anthony O. Udekwu United States 17 293 1.1× 200 0.9× 49 0.2× 101 0.5× 66 0.4× 23 1.5k
Ramón Trullenque Spain 13 445 1.7× 223 1.0× 88 0.4× 30 0.2× 104 0.6× 28 1.9k
Ricardo Fabra Spain 11 428 1.6× 224 1.0× 79 0.4× 29 0.1× 89 0.5× 21 1.8k
Julián Rodrı́guez Spain 21 155 0.6× 139 0.6× 98 0.5× 53 0.3× 110 0.6× 88 1.2k
F. Ulrich Schade Germany 21 435 1.6× 155 0.7× 65 0.3× 31 0.2× 121 0.7× 34 1.3k
Kathy Chang United States 15 970 3.6× 221 1.0× 71 0.4× 66 0.3× 120 0.7× 17 2.6k

Countries citing papers authored by D.A. Shaw

Since Specialization
Citations

This map shows the geographic impact of D.A. Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.A. Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.A. Shaw more than expected).

Fields of papers citing papers by D.A. Shaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.A. Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.A. Shaw. The network helps show where D.A. Shaw may publish in the future.

Co-authorship network of co-authors of D.A. Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of D.A. Shaw. A scholar is included among the top collaborators of D.A. Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.A. Shaw. D.A. Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martinello, Marianne, Kathy Petoumenos, Jason Grebely, et al.. (2016). Incidence of HCV Reinfection among Treated Individuals with Recently Acquired Infection. Journal of Hepatology. 64(2). S620–S621. 1 indexed citations
2.
Smith, Peter, Catherine Stalin, D.A. Shaw, Nicolas Granger, & Nick D. Jeffery. (2009). Comparison of Two Regimens for the Treatment of Meningoencephalomyelitis of Unknown Etiology. Journal of Veterinary Internal Medicine. 23(3). 520–526. 39 indexed citations
3.
Nightingale, Simon, Elaine Woo, Anthony D. Smith, et al.. (2009). Red blood cell and adipose tissue fatty acids in mild inactive multiple sclerosis. Acta Neurologica Scandinavica. 82(1). 43–50. 11 indexed citations
4.
Shaw, D.A., et al.. (2002). Benign intracranial hypertension in a patient with chronic renal failure, precipitated by hemodialysis. Clinical Nephrology. 58(12). 458–460. 1 indexed citations
5.
Overbosch, D., Herbert Schilthuis, Ulrich Bienzle, et al.. (2001). Atovaquone‐Proguanil versus Mefloquine for Malaria Prophylaxis in Nonimmune Travelers: Results from a Randomized, Double‐Blind Study. Clinical Infectious Diseases. 33(7). 1015–1021. 176 indexed citations
6.
Bates, David, N.E.F. Cartlidge, Margaret Jackson, et al.. (1989). A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis.. Journal of Neurology Neurosurgery & Psychiatry. 52(1). 18–22. 136 indexed citations
7.
Barnes, M P, et al.. (1987). Hyperbaric oxygen and multiple sclerosis: final results of a placebo-controlled, double-blind trial.. Journal of Neurology Neurosurgery & Psychiatry. 50(11). 1402–1406. 26 indexed citations
8.
Gray, C, Roy Taylor, J.M. French, et al.. (1987). The Prognostic Value of Stress Hyperglycaemia and Previously Unrecognized Diabetes in Acute Stroke. Diabetic Medicine. 4(3). 237–240. 98 indexed citations
9.
Shaw, D.A., et al.. (1980). Plasma exchange to control sweats and pruritus in malignant disease.. BMJ. 281(6253). 1459.1–1459. 1 indexed citations
10.
Venables, G.S., S.J. Proctor, David O. Bates, N.E.F. Cartlidge, & D.A. Shaw. (1980). Intracranial Disease in Non-Hodgkin's Lymphoma. QJM. 49(194). 111–31. 11 indexed citations
11.
Bates, David O., P. Fawcett, D.A. Shaw, & Andrew Weightman. (1978). Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis.. BMJ. 2(6149). 1390–1391. 86 indexed citations
12.
Venables, G.S., David O. Bates, & D.A. Shaw. (1978). Hypothyroidism with true myotonia.. Journal of Neurology Neurosurgery & Psychiatry. 41(11). 1013–1015. 16 indexed citations
13.
Bates, David O., P. Fawcett, D.A. Shaw, & Andrew Weightman. (1977). Trail of polyunsaturated fatty acids in non-relapsing multiple sclerosis.. BMJ. 2(6092). 932.2–933. 31 indexed citations
14.
Shaw, D.A. & N.E.F. Cartlidge. (1976). Cervical myelopathy in rheumatoid arthritis.. PubMed. 76(5-6). 279–82. 5 indexed citations
15.
Shaw, D.A.. (1972). Investigation of stroke.. BMJ. 1(5792). 91–93. 2 indexed citations
16.
Shaw, D.A.. (1971). Epidemiology of cerebrovascular disease. Journal of the Neurological Sciences. 14(2). 238–238. 5 indexed citations
17.
Stevens, Jack, N.E.F. Cartlidge, Michael D. Saunders, et al.. (1971). Atlanto-Axial Subluxation and Cervical Myelopathy in Rheumatoid Arthritis. QJM. 40(159). 391–408. 74 indexed citations
18.
Hill, A. Bradford, John Marshall, & D.A. Shaw. (1962). Cerebrovascular Disease: Trial of Long-term Anticoagulant Therapy. BMJ. 2(5311). 1003–1006. 67 indexed citations
19.
Marshall, John & D.A. Shaw. (1960). ANTICOAGULANT THERAPY IN ACUTE CEREBROVASCULAR ACCIDENTS. The Lancet. 275(7132). 995–998. 43 indexed citations
20.
Shaw, D.A. & L. J. P. Duncan. (1958). OPTIC ATROPHY AND NERVE DEAFNESS IN DIABETES MELLITUS. Journal of Neurology Neurosurgery & Psychiatry. 21(1). 47–49. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026